STOCK TITAN

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services, has announced its plans to release its third quarter 2024 financial and operating results after market close on Thursday, November 7, 2024. The company will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

Interested parties can participate in the conference call by dialing (888) 596-4144 or (646) 968-2525 and referencing Maravai LifeSciences, Conference ID 9502421. Additionally, a live or archived webcast of the call will be available on the "Investors" section of the Maravai website at https://investors.maravai.com.

Maravai LifeSciences (NASDAQ: MRVI), fornitore globale di reagenti e servizi per le scienze della vita, ha annunciato i suoi piani per rilasciare i risultati finanziari e operativi del terzo trimestre 2024 dopo la chiusura del mercato, il giovedì 7 novembre 2024. L'azienda organizzerà una teleconferenza e un webcast lo stesso giorno alle 2:00 p.m. PT/5:00 p.m. ET.

Le parti interessate possono partecipare alla teleconferenza componendo il numero (888) 596-4144 o (646) 968-2525 e facendo riferimento a Maravai LifeSciences, ID Conferenza 9502421. Inoltre, un webcast dal vivo o registrato della chiamata sarà disponibile nella sezione

Maravai LifeSciences (NASDAQ: MRVI), un proveedor global de reactivos y servicios de ciencias de la vida, ha anunciado sus planes para publicar los resultados financieros y operativos del tercer trimestre de 2024 después del cierre del mercado el jueves 7 de noviembre de 2024. La empresa llevará a cabo una conferencia telefónica y un webcast el mismo día a las 2:00 p.m. PT/5:00 p.m. ET.

Las partes interesadas pueden participar en la conferencia telefónica marcando (888) 596-4144 o (646) 968-2525 y haciendo referencia a Maravai LifeSciences, ID de conferencia 9502421. Además, un webcast en vivo o grabado de la llamada estará disponible en la sección

Maravai LifeSciences (NASDAQ: MRVI), 생명 과학 시약 및 서비스를 제공하는 글로벌 업체가 2024년 3분기 재무 및 운영 결과2024년 11월 7일 목요일 시장 마감 후 발표할 계획이라고 발표했습니다. 이 회사는 같은 날 오후 2시 PT/오후 5시 ET에 전화 회의 및 웹캐스트를 진행할 것입니다.

관심 있는 당사자는 (888) 596-4144 또는 (646) 968-2525로 전화를 걸고 Maravai LifeSciences, 회의 ID 9502421을 언급하여 전화 회의에 참여할 수 있습니다. 또한, 통화의 생방송 또는 아카이브 웹캐스트는 Maravai 웹사이트의

Maravai LifeSciences (NASDAQ: MRVI), un fournisseur mondial de réactifs et de services en sciences de la vie, a annoncé ses plans de publier ses résultats financiers et opérationnels du troisième trimestre 2024 après la fermeture du marché le jeudi 7 novembre 2024. L'entreprise organisera une conférence téléphonique et un webcast le même jour à 14h00 PT/17h00 ET.

Les parties intéressées peuvent participer à la conférence en composant le (888) 596-4144 ou (646) 968-2525 et en se référant à Maravai LifeSciences, ID de conférence 9502421. De plus, un webcast en direct ou archivé de l'appel sera disponible dans la section

Maravai LifeSciences (NASDAQ: MRVI), ein globaler Anbieter von Reagenzien und Dienstleistungen für die Lebenswissenschaften, hat seine Pläne bekannt gegeben, die finanziellen und betrieblichen Ergebnisse für das dritte Quartal 2024 nach Marktende am Donnerstag, den 7. November 2024 zu veröffentlichen. Das Unternehmen wird am selben Tag um 14:00 Uhr PT/17:00 Uhr ET eine Telefonkonferenz und einen Webcast abhalten.

Interessierte Parteien können an der Telefonkonferenz teilnehmen, indem sie (888) 596-4144 oder (646) 968-2525 wählen und sich auf Maravai LifeSciences, Konferenz-ID 9502421, beziehen. Darüber hinaus wird ein Live- oder archivierter Webcast des Anrufs im Bereich

Positive
  • None.
Negative
  • None.

SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2024 financial and operating results after the market closes on Thursday, November 7, 2024, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

To participate in the conference call by telephone, dial (888) 596-4144 or (646) 968-2525 and reference Maravai LifeSciences, Conference ID 9502421. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.

About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.


FAQ

When will Maravai LifeSciences (MRVI) release its Q3 2024 financial results?

Maravai LifeSciences (MRVI) will release its third quarter 2024 financial and operating results after the market closes on Thursday, November 7, 2024.

What time is Maravai LifeSciences' (MRVI) Q3 2024 earnings conference call?

Maravai LifeSciences' (MRVI) Q3 2024 earnings conference call is scheduled for Thursday, November 7, 2024, at 2:00 p.m. PT/ 5:00 p.m. ET.

How can I participate in Maravai LifeSciences' (MRVI) Q3 2024 earnings call?

You can participate in Maravai LifeSciences' (MRVI) Q3 2024 earnings call by dialing (888) 596-4144 or (646) 968-2525 and referencing Conference ID 9502421, or by accessing the webcast on the 'Investors' section of Maravai's website.

Where can I find the webcast for Maravai LifeSciences' (MRVI) Q3 2024 earnings call?

The webcast for Maravai LifeSciences' (MRVI) Q3 2024 earnings call will be available on the 'Investors' section of the company's website at https://investors.maravai.com.

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

MRVI Rankings

MRVI Latest News

MRVI Stock Data

1.10B
141.55M
1.36%
105.45%
6.51%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SAN DIEGO